Gofen & Glossberg LLC IL Takes Position in Roche Holding Ltd. (RHHBY)

Gofen & Glossberg LLC IL bought a new position in Roche Holding Ltd. (OTCMKTS:RHHBY) in the fourth quarter, HoldingsChannel.com reports. The firm bought 8,442 shares of the company’s stock, valued at approximately $267,000.

A number of other hedge funds also recently added to or reduced their stakes in RHHBY. Lenox Wealth Management Inc. boosted its stake in Roche by 49.0% in the 3rd quarter. Lenox Wealth Management Inc. now owns 98,282 shares of the company’s stock worth $3,145,000 after purchasing an additional 32,335 shares in the last quarter. Patten Group Inc. boosted its stake in Roche by 12.2% in the 3rd quarter. Patten Group Inc. now owns 29,741 shares of the company’s stock worth $847,000 after purchasing an additional 3,239 shares in the last quarter. Sterling Capital Management LLC boosted its stake in Roche by 4.6% in the 3rd quarter. Sterling Capital Management LLC now owns 58,107 shares of the company’s stock worth $1,856,000 after purchasing an additional 2,535 shares in the last quarter. Stonebridge Capital Advisors LLC acquired a new stake in Roche in the 3rd quarter worth approximately $221,000. Finally, Parametric Portfolio Associates LLC boosted its stake in Roche by 5.6% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 3,806,074 shares of the company’s stock worth $121,794,000 after purchasing an additional 200,394 shares in the last quarter. Institutional investors own 0.58% of the company’s stock.

Roche Holding Ltd. (OTCMKTS RHHBY) opened at $30.45 on Thursday. The company has a current ratio of 1.29, a quick ratio of 0.92 and a debt-to-equity ratio of 0.66. Roche Holding Ltd. has a 1-year low of $28.48 and a 1-year high of $36.82.

Several brokerages have commented on RHHBY. ValuEngine upgraded shares of Roche from a “hold” rating to a “buy” rating in a research note on Tuesday. Societe Generale cut shares of Roche from a “hold” rating to a “sell” rating in a research note on Monday. Zacks Investment Research cut shares of Roche from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. JPMorgan Chase & Co. restated an “overweight” rating on shares of Roche in a research note on Friday, December 29th. Finally, Piper Jaffray Companies restated a “buy” rating on shares of Roche in a research note on Thursday, December 7th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $36.50.

TRADEMARK VIOLATION WARNING: “Gofen & Glossberg LLC IL Takes Position in Roche Holding Ltd. (RHHBY)” was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.com-unik.info/2018/01/18/gofen-glossberg-llc-il-takes-position-in-roche-holding-ltd-rhhby.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding Ltd. (OTCMKTS:RHHBY).

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit